Cover Image
市場調查報告書

動物用疫苗市場 (各動物:寵物,家畜,各技術:滅活疫苗,弱毒化疫苗,共軛疫苗,類毒素疫苗) - 全球產業分析,規模,佔有率,成長,趨勢,及2016∼2024年的預測

Veterinary Vaccines Market (Animal Type - Companion Animals, Livestock Animals; Technology - Inactivated Vaccines, Live Attenuated Vaccines, Conjugate Vaccines, Toxoid Vaccines) Global Industry Analysis, Size, Share, Growth, Trends, Forecast 2016 - 2024

出版商 Transparency Market Research 商品編碼 372780
出版日期 內容資訊 英文 185 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
動物用疫苗市場 (各動物:寵物,家畜,各技術:滅活疫苗,弱毒化疫苗,共軛疫苗,類毒素疫苗) - 全球產業分析,規模,佔有率,成長,趨勢,及2016∼2024年的預測 Veterinary Vaccines Market (Animal Type - Companion Animals, Livestock Animals; Technology - Inactivated Vaccines, Live Attenuated Vaccines, Conjugate Vaccines, Toxoid Vaccines) Global Industry Analysis, Size, Share, Growth, Trends, Forecast 2016 - 2024
出版日期: 2016年08月19日 內容資訊: 英文 185 Pages
簡介

全球動物用疫苗市場,預計從2015年的62億7,000萬美元規模以年複合成長率6.9%擴大到2024年的114億美元。人畜共通感染疾病的罹患率上升,寵物飼主對寵物的健康保健的投資,政府及非官方機構對動物的疾病和有效的治療方法相關教育的配合措施等,加速今後數年的市場成長。

本報告提供全球動物用疫苗市場相關調查,市場的各動物,各技術,各地區收益預測,及參與企業簡介彙整。

第1章 序論

第2章 假設和調查方法

第3章 摘要整理

第4章 市場概要

  • 產品概要
  • 主要的產業活動
  • 全球的流行病
  • 影響家畜的主要媒介傳播疾病
  • 2010∼2014年代表各種病毒庫的國家
  • 各國動物數
  • 法律規章方案

第5章 市場趨勢

  • 推動市場因素和阻礙因素
  • 促進要素
  • 阻礙要素
  • 機會
  • 閒置頻段分析

第6章 各技術市場分析

  • 主要調查結果
  • 簡介
  • 不活化疫苗
  • 弱毒化疫苗
  • 共軛疫苗
  • 類毒素疫苗
  • 重組的疫苗
  • DNA疫苗
  • 主要趨勢
  • 各技術市場的魅力度分析

第7章 各動物市場分析

  • 主要調查結果
  • 簡介
  • 寵物市場價值佔有率分析
  • 家畜市場價值佔有率分析
  • 主要趨勢
  • 各動物市場魅力度分析

第8章 各地區市場分析

  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東、非洲
  • 各地區方案
  • 各地區市場的魅力度分析

第9章 北美市場

第10章 歐洲市場

第11章 亞太地區市場

第12章 南美市場

第13章 中東、非洲市場

第14章 競爭環境

  • 各國市場佔有率分析
  • 競爭矩陣
  • 企業簡介
    • Bayer AG
    • Bimeda, Inc.
    • Boehringer Ingelheim GmbH
    • Ceva Sante Animale
    • Eli Lilly and Company
    • Merck Animal Health
    • Sanofi S.A.
    • Virbac
    • Zoetis, Inc.

圖表

目錄

A vast surge in the prevalence of zoonotic diseases, increased expenditures on the health and wellness of companion animals by pet lovers, and efforts by government and non-government organizations to educate masses about animal diseases and their effective treatment have collectively fueled the global veterinary vaccines market in the past few years. In the next few years, rising investments by key vendors on R&D activities are expected to lead to the development of highly effective varieties of vaccines such as subunit vaccines, DNA vaccines, and recombinant vaccines. This will have a huge impact on the overall growth prospects of the global veterinary vaccines market.

Transparency Market Research states that the global veterinary vaccines market, which held an opportunity worth US$6.27 bn in 2015, will exhibit a healthy 6.9% CAGR from 2016 through 2024, and rise to a valuation of US$11.40 bn by 2024.

Live Attenuated Vaccines Emerge as Leading Contributor to Market's Revenues

Of the key varieties of veterinary vaccines available in the global market, the segment of live attenuated vaccines presently dominates. The segment held a share of more than 44% in the global market in 2015. Expected to expand at a healthy 6.8% CAGR over the period between 2016 and 2024, the segment is expected to retain its dominance in the global market in the next few years as well. Factors such as easy transport, durability, affordability, safety, and ease of administration work in favor of these vaccine types.

As the production of live attenuated vaccines incurs comparatively low costs than inactivated vaccines and can be produced in bulk, their market is expected to flourish especially in developing regions. Over the period between 2016 and 2024, however, the market for technologically advanced product varieties such as DNA vaccines, subunit vaccines, and recombinant vaccines is expected to expand at the fastest CAGR of 9.2%. Factors such as high level of safety and no use of adjuvants will help these vaccines gain increased attention from pet and farm animal owners.

image1

North America Leads but Emerging Economies to Present Promising Growth Opportunities

North America is presently the key regional market for veterinary vaccines, accounting for nearly 37% of the overall revenues of the global veterinary vaccines market in 2015. The vast rise in pet ownership in the region, especially in the U.S., which has the world's largest number of pets, is central to the massive demand for veterinary vaccines in the region. The market for veterinary vaccines in North America is also driven owing to the strict regulations put in place by the federal government mandating vaccination against certain viruses such as parvovirus, rabies, and adenovirus. Continuous research and progress in the field of veterinary immunology and immunopathology have also kept the region at the forefront of the global veterinary vaccines market.

Though the North America veterinary vaccines market will continue to be in a commanding position over the forecasting horizon in terms of revenue contribution, emerging markets such as Latin America, Asia Pacific, and Middle East and Africa are expected to provide the most promising returns. The vast rise in the number of companion and farm animals across these regions, rising awareness about vaccination among the population, and the rise in prevalence of zoonotic disease will drive the markets for veterinary vaccines in these regions. The market in Asia Pacific will exhibit a strong CAGR of 8.4% over the period between 2016 and 2024.

Some of the key vendors in the global veterinary vaccines market are Ceva Santé Animale, Bayer AG, Bimeda, Inc., Merck Animal Health, Sanofi (Merial Animal Health), Boehringer Ingelheim GmbH, Eli Lilly and Company (Elanco Animal Health), Virbac, and Zoetis, Inc.

Report Description

Veterinary vaccines are extensively used in the prevention of life-threatening animal diseases. This report on the global veterinary vaccines market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, which includes a market snapshot providing overall information on various segments and sub-segments. This section also provides complete information and data analysis of the global veterinary vaccines market with respect to the leading market segments based on technology type, animal type, and geography.

The report is a combination of primary and secondary research. Primary research formed the bulk of our research efforts with information collected from telephonic interviews and interactions via email. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various national and international databases. The report provides market size in terms of US$ Mn for each segment for the period from 2014 to 2024, considering the macro and micro-environmental factors. Growth rates for each segment within the global veterinary vaccines market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, vaccination expenditure, and regulatory requirements.

Increase in prevalence of animal diseases, surge in investments by government bodies, rise in demand for milk, meat, eggs, and fish; high expenditure on companion animals, and growing awareness about vaccination among the middle class are the major factors that propel demand for veterinary vaccines. Stringent market regulations and high R&D cost are the major factors likely to hamper the veterinary vaccines market.

The market overview section of the report includes qualitative analysis of the overall veterinary vaccines market including the determining factors and market dynamics such as drivers, restraints, and opportunities, along with white space analysis. In addition, market attractiveness analysis by geography, animal type, and technology type, and competitive landscape by key players have been provided which explain the intensity of competition in the market considering different geographies. The competitive scenario between market players has been evaluated through market share analysis. These factors would help the market players take strategic decisions in order to strengthen their positions and increase their shares in the global market.

The global veterinary vaccines market has been segmented based on technology type, animal type, and geography. Based on technology type, the market has been categorized into inactivated vaccines, live attenuated vaccines, conjugate vaccines, toxoid vaccines, and other vaccines such as recombinant vaccines, DNA vaccines, and subunit vaccines. Companion vaccines and livestock vaccines are the major segments by animal type. The companion vaccines segment comprises canine vaccines, feline vaccines, and equine vaccines. The livestock vaccines segment includes porcine, poultry, bovine, ovine, and other vaccines. Market revenue in terms of US$ Mn for the period between 2014 and 2024 along with the compound annual growth rate (CAGR %) from 2016 to 2024 has been provided for all the segments, considering 2015 as the base year.

Geographically, the veterinary vaccines market has been categorized into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The mentioned regions are further analyzed by major countries contributing to the market. The competition matrix section included in the report is likely to assist the existing players to increase their market shares and new companies to establish their presence in the veterinary vaccines market. The report also profiles major players based on various attributes such as company overview, financial overview, business strategies, product portfolio, and recent developments. Major players in the global veterinary vaccines market are Bayer AG, Bimeda, Inc., Boehringer Ingelheim GmbH, Ceva Santé Animale, Eli Lilly and Company (Elanco Animal Health), Merck Animal Health, Sanofi S.A. (Merial Animal Health), Virbac, and Zoetis, Inc.

The global veterinary vaccines market has been segmented as follows:

Global Veterinary Vaccines Market, by Animal Type

  • Animal Type
    • Companion Animals
      • Equine
      • Canine
      • Feline
    • Livestock Animals
      • Bovine
      • Ovine
      • Porcine
      • Poultry
      • Others

Global Veterinary Vaccines Market, by Technology Type

  • Inactivated Vaccines
  • Live Attenuated Vaccines
  • Conjugate Vaccines
  • Toxoid Vaccines
  • Other Vaccines

Global Veterinary Vaccines Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
  • Asia Pacific
    • China
    • Japan
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • Saudi Arabia
    • Rest of MEA

Table of Contents

Chapter 1 Preface

  • 1.1 Research Scope
  • 1.2 Market Segmentation
  • 1.3 Research Objectives
  • 1.4 Key Questions Answered

Chapter 2 Assumptions and Research Methodology

  • 2.1 Report Assumptions
  • 2.2 Acronyms Used
  • 2.3 Research Methodology

Chapter 3 Executive Summary

  • 3.1 Global Veterinary Vaccines Market Snapshot
  • 3.2 Market Opportunity Map

Chapter 4 Market Overview

  • 4.1 Product Overview
  • 4.2 Key Industry Events
  • 4.3 Disease Outbreak Globally: Livestock Animals Disease
  • 4.4 Main (Vector Borne Disease) VBDs affecting livestock
  • 4.5 List of countries representing each virus pool (FMD) for the period 2010-2014
  • 4.6 Animal Population (Mn), by Country in 2015
  • 4.7 Regulatory Scenario

Chapter 5 Market Dynamics

  • 5.1 Drivers and Restraints Snapshot Analysis
  • 5.2 Drivers
  • 5.3 Restraints
  • 5.4 Opportunities
  • 5.5 White Space Analysis

Chapter 6 Veterinary Vaccines Market Analysis, by Technology Type, (US$ Mn) 2014-2024

  • 6.1 Key Findings
  • 6.2 Introduction
  • 6.3 Inactivated Vaccines
  • 6.4 Live Attenuated Vaccines
  • 6.5 Conjugate Vaccines
  • 6.6 Toxoid Vaccines
  • 6.7 Recombinant Vaccines
  • 6.8 DNA Vaccines
  • 6.9 Key Trends
  • 6.10 Veterinary Vaccines Market Attractiveness Analysis, by Technology Type, 2015

Chapter 7 Veterinary Vaccines Market Analysis, by Animal Type, (US$ Mn), 2014-2024

  • 7.1 Key Findings
  • 7.2 Introduction
  • 7.3 Veterinary vaccines (companion animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2014-2024
    • 7.3.1 Equine
    • 7.3.2 Canine
    • 7.3.3 Feline
  • 7.4 Veterinary vaccines (livestock animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2014-2024
    • 7.4.1 Bovine
    • 7.4.2 Ovine
    • 7.4.3 Porcine
    • 7.4.4 Poultry
  • 7.5 Key Trends
  • 7.6 Veterinary Vaccines Market Attractiveness Analysis, by Animal Type

Chapter 8 Veterinary Vaccines Market Analysis, by Region, (US$ Mn), 2014-2024

  • 8.1 North America
  • 8.2 Europe
  • 8.3 Asia Pacific
  • 8.4 Latin America
  • 8.5 Middle East & Africa
  • 8.6 Geographical Scenario
  • 8.7 Veterinary Vaccines Market Attractiveness Analysis, by Region, 2015

Chapter 9 North America Veterinary Vaccines Market Analysis, (US$ Mn), 2014-2024

  • 9.1 North America Veterinary Vaccines Market Value Share Analysis, by Technology Type, (US$ Mn), 2014-2024
    • 9.1.1 Inactivated Vaccines
    • 9.1.2 Conjugate Vaccines
    • 9.1.3 Live Attenuated Vaccines
    • 9.1.4 Toxoid Vaccines
    • 9.1.5 Other Vaccines
  • 9.2 North America Veterinary Vaccines Market Value Share Analysis, by Animal Type, (US$ Mn), 2014-2024
    • 9.2.1 Animal Type
      • 9.2.1.1 Companion Animals
        • 9.2.1.1.1 Equine
        • 9.2.1.1.2 Canine
        • 9.2.1.1.3 Feline
      • 9.2.1.2 Livestock Animals
        • 9.2.1.2.1 Bovine
        • 9.2.1.2.2 Ovine
        • 9.2.1.2.3 Porcine
        • 9.2.1.2.4 Poultry
        • 9.2.1.2.5 Others
  • 9.3 U.S. Veterinary Vaccines Market Analysis, (US$ Mn), 2014-2024
  • 9.4 Canada Veterinary Vaccines Market Analysis, (US$ Mn), 2014-2024

Chapter 10 Europe Veterinary vaccines Market Revenue Analysis, (US$ Mn), 2014-2024

  • 10.1 Europe Veterinary Vaccines Market Value Share Analysis, by Technology Type, (US$ Mn), 2014-2024
    • 10.1.1 Inactivated Vaccines
    • 10.1.2 Conjugate Vaccines
    • 10.1.3 Live Attenuated Vaccines
    • 10.1.4 Toxoid Vaccines
    • 10.1.5 Other Vaccines
  • 10.2 Europe Veterinary Vaccines Market Value Share Analysis, by Animal Type, (US$ Mn), 2014-2024
    • 10.2.1 Animal Type
      • 10.2.1.1 Companion Animals
        • 10.2.1.1.1 Equine
        • 10.2.1.1.2 Canine
        • 10.2.1.1.3 Feline
      • 10.2.1.2 Livestock Animals
        • 10.2.1.2.1 Bovine
        • 10.2.1.2.2 Ovine
        • 10.2.1.2.3 Porcine
        • 10.2.1.2.4 Poultry
        • 10.2.1.2.5 Others
  • 10.3 Europe Veterinary Vaccines Market Value Share Analysis, by Country, (US$ Mn), 2014-2024
  • 10.4 Germany Veterinary Vaccines Market Analysis, (US$ Mn), 2014-2024
  • 10.5 U.K. Veterinary Vaccines Market Analysis, (US$ Mn), 2014-2024

Chapter 11 Asia Pacific Veterinary Vaccines Market Analysis, (US$ Mn), 2014-2024

  • 11.1 Asia Pacific Veterinary Vaccines Market Value Share Analysis, by Technology Type, (US$ Mn), 2014-2024
    • 11.1.1 Inactivated Vaccines
    • 11.1.2 Conjugate Vaccines
    • 11.1.3 Live Attenuated Vaccines
    • 11.1.4 Toxoid Vaccines
    • 11.1.5 Other Vaccines
  • 11.2 Asia Pacific Veterinary Vaccines Market Value Share Analysis, by Animal Type, (US$ Mn), 2014-2024
    • 11.2.1 Animal Type
      • 11.2.1.1 Companion Animals
        • 11.2.1.1.1 Equine
        • 11.2.1.1.2 Canine
        • 11.2.1.1.3 Feline
      • 11.2.1.2 Livestock Animals
        • 11.2.1.2.1 Bovine
        • 11.2.1.2.2 Ovine
        • 11.2.1.2.3 Porcine
        • 11.2.1.2.4 Poultry
        • 11.2.1.2.5 Others
  • 11.3 Asia Pacific Veterinary Vaccines Market Value Share Analysis, by Country, (US$ Mn), 2014-2024
  • 11.4 China Veterinary Vaccines Market Analysis, (US$ Mn), 2014-2024
  • 11.5 Japan Veterinary Vaccines Market Analysis, (US$ Mn), 2014-2024

Chapter 12 Latin America Veterinary vaccines Market Revenue Analysis, (US$ Mn), 2014-2024

  • 12.1 Latin America Veterinary Vaccines Market Value Share Analysis, by Technology Type, (US$ Mn), 2014-2024
    • 12.1.1 Inactivated Vaccines
    • 12.1.2 Conjugate Vaccines
    • 12.1.3 Live Attenuated Vaccines
    • 12.1.4 Toxoid Vaccines
    • 12.1.5 Other Vaccines
  • 12.2 Latin America Veterinary Vaccines Market Value Share Analysis, by Animal Type, (US$ Mn), 2014-2024
    • 12.2.1 Animal Type
      • 12.2.1.1 Companion Animals
        • 12.2.1.1.1 Equine
        • 12.2.1.1.2 Canine
        • 12.2.1.1.3 Feline
      • 12.2.1.2 Livestock Animals
        • 12.2.1.2.1 Bovine
        • 12.2.1.2.2 Ovine
        • 12.2.1.2.3 Porcine
        • 12.2.1.2.4 Poultry
        • 12.2.1.2.5 Others
  • 12.3 Latin America Veterinary Vaccines Market Value Share Analysis, by Country, (US$ Mn), 2014-2024
  • 12.4 Brazil Veterinary Vaccines Market Analysis, (US$ Mn), 2014-2024
  • 12.5 Mexico Veterinary Vaccines Market Analysis, (US$ Mn), 2014-2024

Chapter 13 Middle East & Africa Veterinary Vaccines Market Revenue Analysis, (US$ Mn), 2014-2024

  • 13.1 Middle East & Africa Veterinary Vaccines Market Value Share Analysis, by Technology Type, (US$ Mn), 2014-2024
    • 13.1.1 Inactivated Vaccines
    • 13.1.2 Conjugate Vaccines
    • 13.1.3 Live Attenuated Vaccines
    • 13.1.4 Toxoid Vaccines
    • 13.1.5 Other Vaccines
  • 13.2 Middle East & Africa Veterinary Vaccines Market Value Share Analysis, by Animal Type, (US$ Mn), 2014-2024
    • 13.2.1 Animal Type
      • 13.2.1.1 Companion Animals
        • 13.2.1.1.1 Equine
        • 13.2.1.1.2 Canine
        • 13.2.1.1.3 Feline
      • 13.2.1.2 Livestock Animals
        • 13.2.1.2.1 Bovine
        • 13.2.1.2.2 Ovine
        • 13.2.1.2.3 Porcine
        • 13.2.1.2.4 Poultry
        • 13.2.1.2.5 Others
  • 13.3 Middle East & Africa Veterinary Vaccines Market Value Share Analysis, by Country, (US$ Mn), 2014-2024
  • 13.4 Saudi Arabia Veterinary Vaccines Market Analysis, (US$ Mn), 2014-2024

Chapter 14 Competitive Landscape

  • 14.1 Veterinary Vaccine Market Share Analysis, by Company, (2015)
  • 14.2 Competition Matrix
    • 14.2.1 Bayer AG
    • 14.2.2 Bimeda, Inc.
    • 14.2.3 Boehringer Ingelheim GmbH
    • 14.2.4 Ceva Santé Animale
    • 14.2.5 Eli Lilly and Company (Elanco Animal Health)
    • 14.2.6 Merck Animal Health
    • 14.2.7 Sanofi S.A. (Merial Animal Health)
    • 14.2.8 Virbac
    • 14.2.9 Zoetis, Inc.
  • 14.3 Company Profiles
    • 14.3.1 Bayer AG
      • 14.3.1.1 Company Details
      • 14.3.1.2 Company Description
      • 14.3.1.3 Business Overview
      • 14.3.1.4 SWOT Analysis
      • 14.3.1.5 Financials
      • 14.3.1.6 Strategic Overview
      • 14.3.1.7 Product Portfolio
      • 14.3.1.8 Recent Developments
    • 14.3.2 Bimeda, Inc.
      • 14.3.2.1 Company Details
      • 14.3.2.2 Company Description
      • 14.3.2.3 Business Overview
      • 14.3.2.4 SWOT Analysis
      • 14.3.2.5 Financials
      • 14.3.2.6 Strategic Overview
      • 14.3.2.7 Product Portfolio
      • 14.3.2.8 Recent Developments
    • 14.3.3 Boehringer Ingelheim GmbH
      • 14.3.3.1 Company Details
      • 14.3.3.2 Company Description
      • 14.3.3.3 Business Overview
      • 14.3.3.4 SWOT Analysis
      • 14.3.3.5 Financials
      • 14.3.3.6 Strategic Overview
      • 14.3.3.7 Product Portfolio
      • 14.3.3.8 Recent Developments
    • 14.3.4 Ceva Santé Animale
      • 14.3.4.1 Company Details
      • 14.3.4.2 Company Description
      • 14.3.4.3 Business Overview
      • 14.3.4.4 SWOT Analysis
      • 14.3.4.5 Financials
      • 14.3.4.6 Strategic Overview
      • 14.3.4.7 Product Portfolio
      • 14.3.4.8 Recent Developments
    • 14.3.5 Eli Lilly and Company (Elanco Animal Health)
      • 14.3.5.1 Company Details
      • 14.3.5.2 Company Description
      • 14.3.5.3 Business Overview
      • 14.3.5.4 SWOT Analysis
      • 14.3.5.5 Financials
      • 14.3.5.6 Strategic Overview
      • 14.3.5.7 Product Portfolio
      • 14.3.5.8 Recent Developments
    • 14.3.6 Merck Animal Health
      • 14.3.6.1 Company Details
      • 14.3.6.2 Company Description
      • 14.3.6.3 Business Overview
      • 14.3.6.4 SWOT Analysis
      • 14.3.6.5 Financials
      • 14.3.6.6 Strategic Overview
      • 14.3.6.7 Product Portfolio
      • 14.3.6.8 Recent Developments
    • 14.3.7 Sanofi S.A. (Merial Animal Health)
      • 14.3.7.1 Company Details
      • 14.3.7.2 Company Description
      • 14.3.7.3 Business Overview
      • 14.3.7.4 SWOT Analysis
      • 14.3.7.5 Financials
      • 14.3.7.6 Strategic Overview
      • 14.3.7.7 Product Portfolio
      • 14.3.7.8 Recent Developments
    • 14.3.8 Virbac
      • 14.3.8.1 Company Details
      • 14.3.8.2 Company Description
      • 14.3.8.3 Business Overview
      • 14.3.8.4 SWOT Analysis
      • 14.3.8.5 Financials
      • 14.3.8.6 Strategic Overview
      • 14.3.8.7 Product Portfolio
      • 14.3.8.8 Recent Developments
    • 14.3.9 Zoetis, Inc.
      • 14.3.9.1 Company Details
      • 14.3.9.2 Company Description
      • 14.3.9.3 Business Overview
      • 14.3.9.4 SWOT Analysis
      • 14.3.9.5 Financials
      • 14.3.9.6 Strategic Overview
      • 14.3.9.7 Product Portfolio
      • 14.3.9.8 Recent Developments

List of Figures

  • FIG. 1 Global Veterinary Vaccines Market Value Share Analysis, by Technology Type, (US$ Mn), 2015 and 2024
  • FIG. 2 Global Inactivated Vaccines Market Revenue, (US$ Mn), 2014-2024
  • FIG. 3 Global Live Attenuated Vaccines Market Revenue, (US$ Mn), 2014-2024
  • FIG. 4 Global Conjugate Vaccines Market Revenue, (US$ Mn), 2014-2024
  • FIG. 5 Global Toxoid Vaccines Market Revenue, (US$ Mn), 2014-2024
  • FIG. 6 Global Recombinant Vaccines Market Revenue, (US$ Mn), 2014-2024
  • FIG. 7 Global DNA Vaccines Market Revenue, (US$ Mn), 2014-2024
  • FIG. 8 Global Veterinary Vaccines (companion animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2015 and 2024
  • FIG. 9 Global Equine Vaccines Market Revenue, (US$ Mn), 2014-2024
  • FIG. 10 Global Canine Vaccines Market Revenue, (US$ Mn), 2014-2024
  • FIG. 11 Global Feline Vaccines Market Revenue, (US$ Mn), 2014-2024
  • FIG. 12 Global Companion Animal Vaccines Market Revenue, (US$ Mn), 2014-2024
  • FIG. 13 Global Veterinary Vaccines (livestock animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2015 and 2024
  • FIG. 14 Global Bovine Vaccines Market Revenue, (US$ Mn), 2014-2024
  • FIG. 15 Global Ovine Vaccines Market Revenue, (US$ Mn), 2014-2024
  • FIG. 16 Global Porcine Vaccines Market Revenue, (US$ Mn), 2014-2024
  • FIG. 17 Global Poultry Vaccines Market Revenue, (US$ Mn), 2014-2024
  • FIG. 18 Global Veterinary Vaccines Market Value Share Analysis, by Region, 2015 and 2024
  • FIG. 19 Veterinary Vaccines Market Attractiveness Analysis, by Region, (US$ Mn), 2014-2024
  • FIG. 20 Veterinary Vaccines Market Attractiveness Analysis, by Technology Type, (US$ Mn), 2014-2024
  • FIG. 21 Veterinary Vaccines Market Attractiveness Analysis, by Animal Type, (US$ Mn), 2014-2024
  • FIG. 22 North America Veterinary Vaccines (companion animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2015 and 2024
  • FIG. 23 North America Veterinary Vaccines (livestock animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2015 and 2024
  • FIG. 24 North America Veterinary Vaccines (livestock animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2015 and 2024
  • FIG. 25 North America Market Value Share Analysis, by Country, (US$ Mn), 2015 and 2024
  • U.S. Veterinary Vaccines Market Revenue, (US$ Mn), 2014-2024
  • FIG. 26 U.S. Veterinary Vaccines Market Revenue, (US$ Mn), 2014-2024
  • FIG. 27 Canada Veterinary Vaccines Market Revenue, (US$ Mn), 2014-2024
  • FIG. 28 Europe Veterinary Vaccines Market Value Share Analysis, by Technology Type, (US$ Mn), 2015 and 2024
  • FIG. 29 Europe Veterinary Vaccines (companion animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2015 and 2024
  • FIG. 30 Europe Veterinary Vaccines (livestock animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2015 and 2024
  • FIG. 31 Europe Veterinary Vaccines Market Value Share Analysis, by Country, (US$ Mn), 2015 and 2024
  • FIG. 32 Germany Veterinary Vaccines Market Revenue, (US$ Mn), 2014-2024
  • FIG. 33 U.K. Veterinary Vaccines Market Revenue, (US$ Mn), 2014-2024
  • FIG. 34 Asia Pacific Veterinary Vaccines Market Value Share Analysis, by Technology Type, (US$ Mn), 2015 and 2024
  • FIG. 35 Asia Pacific Veterinary Vaccines (companion animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2015 and 2024
  • FIG. 36 Asia Pacific Veterinary Vaccines (livestock animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2015 and 2024
  • FIG. 37 Asia Pacific Veterinary Vaccines Market Value Share Analysis, by Country, (US$ Mn) 2015 and 2024
  • FIG. 38 China Veterinary Vaccines Market Revenue, (US$ Mn), 2014-2024
  • FIG. 39 Japan Veterinary Vaccines Market Revenue, (US$ Mn), 2014-2024
  • FIG. 40 Latin America Veterinary Vaccines Market Value Share Analysis, by Technology Type, (US$ Mn), 2015 and 2024
  • FIG. 41 Latin America Veterinary Vaccines (companion animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2015 and 2024
  • FIG. 42 Latin America Veterinary Vaccines (livestock animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2015 and 2024
  • FIG. 43 Latin America Market Value Share Analysis, by Country, (US$ Mn), 2015 and 2024
  • FIG. 44 Brazil Veterinary Vaccines Market Revenue, (US$ Mn), 2014-2024
  • FIG. 45 Mexico Veterinary Vaccines Market Revenue, (US$ Mn), 2014-2024
  • FIG. 46 Middle East & Africa Veterinary Vaccines Market Value Share Analysis, by Technology Type, (US$ Mn), 2015 and 2024
  • FIG. 47 Middle East & Africa Veterinary Vaccines (companion animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2015 and 2024
  • FIG. 48 Middle East & Africa Veterinary Vaccines (livestock animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2015 and 2024
  • FIG. 49 Saudi Arabia Veterinary Vaccines Market Revenue, (US$ Mn), 2014-2024
  • FIG. 50 Global Veterinary Vaccines Market Share Analysis, by Company (%) (2015)

List of Tables

  • Table 1. Global Veterinary Vaccines Market Size Forecast, by Technology Type, (US$ Mn), 2014-2024
  • Table 2. Global Veterinary Vaccines (companion animals) Market Size Forecast, by Animal Type, (US$ Mn), 2014-2024
  • Table 3. Global Veterinary Vaccines (livestock animals) Market Size Forecast, by Animal Type, (US$ Mn), 2014-2024
  • Table 4. Global Veterinary Vaccines Market Size Forecast, by Region, (US$ Mn), 2014-2024
  • Table 5. North America Veterinary Vaccines Market Size Forecast, by Technology Type, (US$ Mn), 2014-2024
  • Table 6. Global Veterinary Vaccines (companion animals) Forecast, by Animal Type, (US$ Mn), 2014-2024
  • Table 7. Global Veterinary Vaccines (livestock animals) Market Size Forecast, by Animal Type, (US$ Mn), 2014-2024
  • Table 8. North America Veterinary Vaccines Market Size Forecast, by Country, (US$ Mn), 2014-2024
  • Table 9. Europe Veterinary Vaccines Market Size Forecast, by Technology Type, (US$ Mn), 2014-2024
  • Table 10. Europe Veterinary Vaccines (companion animals) Forecast, by Animal Type, (US$ Mn), 2014-2024
  • Table 11. Europe Veterinary Vaccines (livestock animals) Market Size (US$ Mn) Forecast, by Animal Type, (US$ Mn), 2014-2024
  • Table 12. Europe Veterinary Vaccines Market Size Forecast, by Country, (US$ Mn), 2014-2024
  • Table 13. Asia Pacific Veterinary Vaccines Market Size Forecast, by Technology Type, (US$ Mn), 2014-2024
  • Table 14. Asia Pacific Veterinary Vaccines (companion animals) Forecast, by Animal Type, (US$ Mn), 2014-2024
  • Table 15. Asia Pacific Veterinary Vaccines (livestock animals) Market Size Forecast, by Animal Type, (US$ Mn), 2014-2024
  • Table 16. Asia Pacific Veterinary Vaccines Market Size Forecast, by Country, (US$ Mn), 2014-2024
  • Table 17. Latin America Veterinary Vaccines Market Size (US$ Mn) Forecast, by Technology Type, (US$ Mn), 2014-2024
  • Table 18. Latin America Veterinary Vaccines (companion animals) Forecast, by Animal Type, (US$ Mn), 2014-2024
  • Table 19. Latin America Veterinary Vaccines (livestock animals) Market Size (US$ Mn) Forecast, by Animal Type, (US$ Mn), 2014-2024
  • Table 20. Latin America Veterinary Vaccines Market Size Forecast, by Country, (US$ Mn), 2014-2024
  • Table 21. Middle East & Africa Veterinary Vaccines Market Size Forecast, by Technology Type, (US$ Mn), 2014-2024
  • Table 22. Middle East & Africa Veterinary Vaccines (companion animals) Forecast, by Animal Type, (US$ Mn), 2014-2024
  • Table 23. Middle East & Africa Veterinary Vaccines (livestock animals) Market Size (US$ Mn) Forecast, by Animal Type, (US$ Mn), 2014-2024
  • Table 24. Middle East & Africa Veterinary Vaccines Market Size Forecast, by Country, (US$ Mn), 2014-2024
Back to Top